USD10
NVO Shares
About Novo NordiskWith roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
USD10
NVO Shares
About Novo NordiskWith roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$163.95B
OPEN PRICE
$36.09
LOW (1Y)
$43.08
HIGH (1Y)
$93.80
LOW (24H)
$35.63
HIGH (24H)
$36.98
VOLUME (24H)
$14.80M
38.55%
Price history
Time | Price | Change |
|---|---|---|
Today | $36.09 | |
1 Day | $36.98 | |
1 Week | $35.59 | |
1 Month | $37.76 | |
1 Year | $63.64 |